Freeway
Arizona

Phoenix

Freeway partner cityData as of Oct 1, 2026
2,570
Companies
$58.2M
Venture funding in the last 12 months, 10 rounds
$1.0B
Venture funding, 2022–2026
152
Investor firms

Venture funding by year

* 2026 through Oct 2026. Rounds without a disclosed amount count as rounds, not dollars.
Show as a table
YearVenture fundingRounds
2019$516.9M66
2020$535.2M50
2021$273.9M59
2022$329.9M62
2023$288.3M54
2024$105.7M31
2025$248.9M29
2026*$57.8M8

Industries

  • Health304
  • Enterprise software198
  • Fintech179
  • Marketing169
  • Real estate146
  • Education115
  • Media104
  • Food96
  • Energy83
  • Transportation79

And 20 more industries.

Companies in Phoenix

745–768 of 2,570 companies

  • English Dermatology is a dermatological practice providing medical, surgical, and cosmetic services across multiple locations in the greater Phoenix, Arizona area. Dr. English, a graduate of the University of Utah School of Medicine, is certified by the American Board of Dermatology and is a Fellow of the American Academy of Dermatology. He has been practicing in Arizona since 1990 and has served as a team dermatologist for the Arizona Diamondbacks since 1999. The practice serves patients of all ages, offering diagnosis and treatment for a wide range of skin conditions, including skin cancer, acne, psoriasis, and rosacea. The business operates through a network of clinics staffed by board-certified dermatologists, surgeons, and other healthcare providers. Services are categorized into medical, surgical, and cosmetic dermatology. Medical services focus on preventative, diagnostic, and corrective treatments for skin disorders. Surgical dermatology utilizes advanced technologies, including Mohs surgery, for conditions like skin cancer. Cosmetic treatments address aesthetic concerns such as wrinkles and acne scars. The company's business model is a fee-for-service medical group practice. It has expanded over the years to include numerous locations throughout the Phoenix metropolitan area, such as San Tan Valley, Desert Ridge, Mesa, and Casa Grande, making it a significant regional provider of dermatological care. The practice is part of the West Dermatology family of practices.

    Early stage · 11–50 employees

  • Enkoat

    Energy

    Enkoat is an advanced materials company operating in the clean-tech sector, focused on enhancing the energy efficiency and climate resiliency of buildings. Officially founded in 2018, Enkoat was established to commercialize this research into energy-efficient solutions for the built environment. Their journey includes participation in the National Science Foundation's I-Corps program, where they conducted over 100 customer discovery interviews to refine their product-market fit. Enkoat's core business revolves around the manufacture and distribution of specialized paints and coatings designed to reduce carbon emissions. The company serves building owners and managers, offering them a way to lower their carbon footprint, protect infrastructure, and reduce operational costs. Revenue is generated through the sale of its coating systems, which are distributed through partners like Gulf Eagle Supply. The company targets clients with strong decarbonization goals who are looking for scalable solutions. Enkoat operates in the building materials and clean technology markets, addressing the estimated $400 billion global problem of inefficient HVAC systems and premature roof failures. The flagship product is the IntelliKoat™ system, a patented, dual-layer thermal and weather barrier. This system consists of a basecoat, ActivTherm™, and a topcoat, DuraFlect™. Unlike traditional reflective coatings that primarily reflect light, IntelliKoat™ utilizes a controlled microstructure for energy absorption and release, managing both conductive and radiant heat. This allows it to perform effectively year-round in various climates. The primary benefits include a reduction in HVAC and cooling energy consumption by up to 30%, a significant extension of a roof's lifespan by 10 to 20 years, and protection against UV, wind, rain, and snow. Rigorous testing by the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) showed the system has up to 7 times improved thermal performance over standard reflective coatings.

    Early stage · 11–50 employees · $240K raised

  • ENLIVENED

    Health

    Sambataro, a former Broadway performer, transitioned into the health and wellness industry after experiencing personal health challenges, including fatigue and poor workout recovery. This personal journey led her to become a certified Functional Diagnostic Nutrition Practitioner (FDN-P), CHEK Holistic Lifestyle Coach, and Corrective Exercise Specialist. The business operates on a personalized coaching model that utilizes functional lab testing and data from wearables to identify the root causes of health issues. Sambataro's approach is based on biochemical individuality, creating customized wellness plans for each client. The services offered include functional health coaching, movement and mobility training, blood sugar and metabolic health analysis, and microdosing guidance. The coaching process often involves the D.R.E.S.S. (Diet, Rest, Exercise, Stress Reduction, Supplementation) protocol to guide clients toward better health. Sambataro also co-hosts the "Biohacker Babes" podcast with her sister, Renee, which explores topics like gut health, metabolism, and biohacking. The business primarily serves individuals who feel stuck with their health, have been let down by conventional medicine, or are looking to optimize their well-being. Movement coaching incorporates methods like kettlebells, animal flow, and corrective exercise, starting with a CHEK Movement Assessment to address dysfunctions.

    Early stage

  • Enreps

    Energy

    The company specializes in the refrigeration, HVAC, and energy industries, with a primary focus on supermarket and retail clients. Enreps' services are designed to ensure that complex building systems are installed and operate correctly, helping facility managers manage risk amidst industry-wide labor shortages and evolving technologies. In February 2026, Enreps was acquired by DC Engineering, a Meridian, Idaho-based engineering firm, and now operates as a wholly-owned subsidiary. This acquisition was a strategic move to enhance the capabilities and capacity of both companies in commissioning and related services, particularly for their shared client base of major national retailers. The merger addresses the growing need for highly skilled commissioning support driven by regulatory changes, such as the transition to CO₂ and other low Global Warming Potential (GWP) refrigerants. The company offers a range of services including new construction commissioning, remodel commissioning, re-commissioning, and retro-commissioning. Their offerings also include test and balance management, electrical infrared inspections to detect faulty wiring, and asset tagging for EPA compliance and refrigerant inventory. For its commissioning work, Enreps developed its own software called "Report Cx". The firm's business model is based on providing specialized consulting and technical services to businesses in the retail and supermarket sectors.

    Early stage · 2–10 employees

  • Early stage

  • Early stage · 11–50 employees

  • Entrepix

    Semiconductors

    Early stage · 51–200 employees

  • Envox Group

    Marketing

    Envox Worldwide operated as a specialized provider of IP-based voice self-service and contact center solutions. The company was founded in 1994 and focused on developing communication platforms and tools for Windows NT-based systems, enabling services like unified messaging, e-commerce, and web automation.The company's core business involved providing both hosted and on-premise Interactive Voice Response (IVR) and Computer-Telephony Integration (CTI) software. These products were designed to reduce customer service costs and enhance contact center performance for its global client base. Its CTI software offered functionalities such as intelligent routing, screen pop, and call monitoring. Envox also supplied development tools and software platforms for unified communications and multimedia carrier services.A significant milestone in the company's history was its acquisition by Enghouse Systems Limited, the parent company of Syntellect, in October 2008 for $14 million. At the time of the acquisition, Envox generated approximately $16 million in annual revenue and had deployed over 1.25 million ports of its IVR solutions globally. The acquisition was a strategic move by Enghouse to integrate Envox's technology portfolio and global distribution channels, particularly in Europe and the Asia-Pacific region, with Syntellect's operations to address a broader spectrum of the contact center market.

    Early stage · 11–50 employees · $5.3M raised

  • Envoy Development

    Enterprise software

    Early stage · 11–50 employees

  • Epic Game Ads

    Marketing

    Early stage · 1 employees

  • EpiPrecision AI is a health technology company specializing in artificial intelligence solutions for the treatment of drug-resistant epilepsy. The firm was founded in 2023 by Harshit Khandelwal and Prateek Jain. Harshit Khandelwal, the CEO, has a background in building and scaling AI and data science teams in the healthcare and life sciences sectors, with experience at companies like Johnson & Johnson and ZS. Prateek Jain, the CTO, brings expertise in AI, machine learning, and deep learning from his time at Microsoft and other tech firms. The company's core offering is an AI-powered software platform designed to improve the accuracy and efficiency of seizure localization for patients undergoing epilepsy surgery. This is significant because surgery is the primary treatment for the more than 20 million people worldwide who do not respond to anti-epileptic drugs. The platform analyzes multi-modal brain data, such as EEG and MRI scans, to help neurologists and surgeons pinpoint the precise origin of seizures. This process aims to enhance surgical planning, predict the most suitable type of surgery for each patient, and ultimately improve the success rates of these procedures. By increasing the precision of interventions, the solution seeks to reduce the need for invasive diagnostic procedures. EpiPrecision AI operates on a B2B model, targeting Level 4 comprehensive epilepsy care centers in the United States as its initial market, with plans for global expansion. The business model aims to help hospitals and neurology institutes increase their surgery success rates, potentially up to 100%, while also increasing the volume of surgeries performed and reducing overall procedural costs by up to 40%. The company was part of the Fall 2023 cohort of the Alchemist Accelerator, a program focused on enterprise startups.

    Early stage

  • EPOXY WERX

    Transportation

    Early stage · 2–10 employees

  • Epoxy2U

    Real estate

    Epoxy2U (E2U) is a manufacturer and distributor of liquid polymer flooring systems, specializing in decorative and protective coatings. The company, headquartered in Phoenix, Arizona, produces its products in the USA using premium ingredients and materials. E2U's product line includes metallic and flake epoxy flooring, polyaspartics, urethanes, and concrete repair compounds. These systems are designed for residential, commercial, and industrial applications such as garages, warehouses, showrooms, hospitals, and kitchens. The company's business model involves direct manufacturing and distribution through a network of authorized dealers and distributors across the United States and internationally, including in Australia. E2U emphasizes product innovation based on decades of on-site experience, offering formulas that can be tailored to specific customer needs. A key aspect of their strategy includes providing professional training classes on product application at their corporate headquarters to ensure quality installations and customer success. Products are developed to be durable, high-gloss, and resistant to chemicals, abrasion, and UV light, with some systems offering rapid cure times for one-day installations.

    Early stage · 11–50 employees

  • Early stage · 2–10 employees

  • EquiCeutica is a pharmaceutical delivery company focused on advancing the cannabidiol (CBD) market for animal and human health. The company addresses the primary challenge of traditional CBD products: low bioavailability due to degradation by stomach acids. To overcome this, EquiCeutica utilizes Liposomal-Nano Encapsulation Technology, a delivery mechanism that protects the active compounds in tiny, spherical vesicles called liposomes. This method shields the CBD from the digestive system and allows for 4–6 times higher absorption compared to standard oils, ensuring a more potent and consistent effect. The company's product line includes precision-dosed, clinical-strength formulations for equine, canine, feline, and human applications. The business model appears to be a hybrid of direct-to-consumer (D2C) sales through its website and business-to-business (B2B) distribution through veterinary professionals. Products are prescribed and sold by veterinarians, and the company is trusted by orthopedic surgeons and equine hospitals in the UK, EU, and USA. EquiCeutica's mission is to become the market leader in veterinary medicinal CBD by securing regulatory authorizations. EquiCeutica's formulations are manufactured to MHRA (Medicines and Healthcare products Regulatory Agency) and GMP (Good Manufacturing Practice) standards and hold an FDA DMF (Drug Master File) number #036876, signifying a commitment to pharmaceutical-grade quality and regulatory compliance. The technology enables unique benefits, such as the ability to penetrate synovial fluid in joints without injections, which is particularly beneficial for managing joint stiffness and mobility issues in performance and senior animals. Case studies and testimonials from veterinary clinicians highlight positive outcomes in treating stress, and improving mobility and general well-being in horses and dogs.

    Early stage · 2–10 employees

  • Early stage · 2–10 employees

  • Early stage

  • Breakout · 51–200 employees

  • eScribers, founded in 2005 in Phoenix, Arizona, specializes in providing high-quality transcription and reporting services across the United States. The company primarily serves courts and government agencies, ensuring accurate and timely court transcripts. eScribers employs experienced, AAERT-certified transcribers to deliver secure and reliable transcription services. The company operates in the legal and governmental market, focusing on improving courtroom processes and services. eScribers generates revenue through service contracts with courts and government entities, offering a subscription-based model for ongoing transcription needs. The company has expanded its market presence through strategic acquisitions, including AVTranz in 2015 and Deposition Services Inc. in 2021. eScribers has also adapted to the changing landscape by developing streamlined processes for remote hearings and transcripts in response to COVID-19.

    Breakout · 201–500 employees · $10.3M raised

  • ESG Hospitality specializes in providing a wide range of tableware, buffetware, furniture, linens, and smallware to the hospitality industry. Operating primarily in the Western United States, including states like Arizona, New Mexico, Utah, Colorado, Wyoming, Montana, Idaho, Washington, Oregon, and Alaska, the company serves restaurants, hotels, and other hospitality venues. ESG Hospitality's business model revolves around supplying high-quality products that meet the specific needs of its clients, ensuring timely delivery and budget adherence. The company generates revenue through the sale of its diverse product offerings, which are tailored to enhance the dining and service experience of its clients' guests. ESG Hospitality is recognized for its professional service and the ability to provide unique design elements that contribute to the successful opening and operation of hospitality establishments.

    Early stage · 2–10 employees

  • Late stage · 10001+ employees

  • Esscentual Brands

    Wellness & beauty

    Early stage · 2–10 employees

  • Early stage · 11–50 employees

  • Esthesis Consulting is the independent product design consultancy of founder Jarel Mitchell. The firm specializes in human-centered design, focusing on creating immersive user experiences that integrate digital and physical touchpoints. The consultancy's work spans areas including AI wearables, IoT environments, and connected commerce. The founder, Jarel Mitchell, took a non-traditional path into the design field. He previously served for 10 years in the US Army as a Military Police Officer and Supply & Logistics Sergeant. This decade in military logistics provided him with a foundation in systems thinking, which now informs his design philosophy of managing complexity and understanding how each component fits within a larger ecosystem. He pivoted his career in 2018, pursuing his interest in the intersection of art, psychology, and computer science. Mitchell graduated from the University of Washington in 2023 with a Bachelor of Science in Human Centered Design & Engineering. He is currently enhancing his expertise by attending the Master of Human-Computer Interaction & Design program at the University of California, Irvine. Operating under a solo consulting model, Mitchell is the direct service provider for Esthesis Consulting's clients. His portfolio also includes a collaboration with the band Avenged Sevenfold on merchandise and the launch of his own streetwear brand in 2024, A Happy Cactus.

    Early stage · 1 employees

Recent venture rounds

CompanyRoundAmountDateInvestors
MiiHealthSeed$2.8MAug 2026Not disclosed
BoreDMSeries AUndisclosedJun 2026Five Elms Capital
Prickly Pear HealthSeedUndisclosedMar 2026Emmeline Ventures
ALTREarly VCUndisclosedMar 2026Branca International
MatturEarly VCUndisclosedFeb 2026Outlier Solutions, Inc.
Oats OvernightGrowth Equity VC$45.0MJan 2026Asto Consumer Partners
COCO5Late VC$10.0MJan 2026Not disclosed
Breakthru MedicineSeries AUndisclosedJan 2026Not disclosed
Steady InstallSeed$400KDec 2025Not disclosed
Cloverleaf NetworksEarly VCUndisclosedDec 2025SuperK Ventures
Investors based here
Accelerators and programs

Source: Dealroom, data as of Oct 1, 2026. Venture funding sums venture-type rounds with a disclosed amount; rounds raised by companies already public or bought out are left out. The last 12 months run from Nov 2025 to Oct 2026.

Founders, team members and individual investors are never shown, and company descriptions have sentences naming people removed.